# Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

> **NCT01503580** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 155 (actual)

## Conditions studied

- Antimuscarinic Drug

## Interventions

- **DRUG:** tolterodine, solifenacin

## Key facts

- **NCT ID:** NCT01503580
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-07
- **Final completion:** 2013-10
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01503580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01503580, "Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01503580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*